دورية أكاديمية
The clinical and bioinformatics analysis for the role of antihypertension drugs on mortality among patients with hypertension hospitalized with COVID-19.
العنوان: | The clinical and bioinformatics analysis for the role of antihypertension drugs on mortality among patients with hypertension hospitalized with COVID-19. |
---|---|
المؤلفون: | Zhao L; Department of Biomedical Sciences, Faculty of Health Sciences, University of Macau, Taipa, Macau, China., Li Y; Department of Biomedical Sciences, Faculty of Health Sciences, University of Macau, Taipa, Macau, China., Yi W; Department of Dermatology, Zhongnan Hospital of Wuhan University, Wuhan, China., Yan K; Institute of Cell and Neurobiology, Charité Medical University, Berlin, Germany., Yang C; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Radhakrishnan S; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore., Li R; Department of Radiation Oncology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China., Tan R; Translational Chinese Medicine Key Laboratory of Sichuan Province, Sichuan Institute for Translational Chinese Medicine, Sichuan Academy of Chinese Medicine Sciences, Chengdu, China., Fan G; Department of Urology, Huazhong University of Science and Technology Union Shenzhen Hospital, The 6th Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen, China., Dai M; Department of Gynecological Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China., Liu M; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Shao NY; Department of Biomedical Sciences, Faculty of Health Sciences, University of Macau, Taipa, Macau, China.; MoE Frontiers Science Center for Precision Oncology, University of Macau, Taipa, Macau SAR, China. |
المصدر: | Journal of medical virology [J Med Virol] 2022 Oct; Vol. 94 (10), pp. 4727-4734. Date of Electronic Publication: 2022 Jun 16. |
نوع المنشور: | Journal Article; Research Support, Non-U.S. Gov't |
اللغة: | English |
بيانات الدورية: | Publisher: Wiley-Liss Country of Publication: United States NLM ID: 7705876 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-9071 (Electronic) Linking ISSN: 01466615 NLM ISO Abbreviation: J Med Virol Subsets: MEDLINE |
أسماء مطبوعة: | Publication: New York Ny : Wiley-Liss Original Publication: New York, Liss. |
مواضيع طبية MeSH: | COVID-19*/complications , Hypertension*/complications , Hypertension*/drug therapy , COVID-19 Drug Treatment*, Angiotensin Receptor Antagonists/therapeutic use ; Angiotensin-Converting Enzyme Inhibitors/therapeutic use ; Antihypertensive Agents/therapeutic use ; Calcium Channel Blockers/therapeutic use ; Computational Biology ; Humans ; Retrospective Studies ; SARS-CoV-2 |
مستخلص: | Comorbidities such as hypertension could exacerbate symptoms of coronaviral disease 2019 (COVID)-19 infection. Patients with hypertension may receive both anti-COVID-19 and antihypertension therapies when infected with COVID-19. However, it is not clear how different classes of anti-hypertension drugs impact the outcome of COVID-19 treatment. Herein, we explore the association between the inpatient use of different classes of anti-hypertension drugs and mortality among patients with hypertension hospitalized with COVID-19. We totally collected data from 278 patients with hypertension diagnosed with COVID-19 admitted to hospitals in Wuhan from February 1 to April 1, 2020. A retrospective study was conducted and single-cell RNA-sequencing (RNA-Seq) analysis of treatment-related genes was performed. The results showed that Angiotensin II receptor blocker (ARB) and calcium channel blocker (CCB) drugs significantly increased the survival rate but the use of angiotensin-converting enzyme inhibitor/β-block/diuretic drugs did not affect the mortality caused by COVID-19. Based on the analysis of four public data sets of single-cell RNA-Seq on COVID-19 patients, we concluded that JUN, LST1 genes may play a role in the effect of ARB on COVID-19-related mortality, whereas CALM1 gene may contribute to the effect of CCB on COVID-19-related mortality. Our results provide guidance on the selection of antihypertension drugs for hypertensive patients infected with COVID-19. (© 2022 The Authors. Journal of Medical Virology published by Wiley Periodicals LLC.) |
التعليقات: | Comment in: J Med Virol. 2023 Jan;95(1):e28319. (PMID: 36397640) |
References: | Lancet. 2021 Sep 11;398(10304):957-980. (PMID: 34450083) Cancer Control. 2020 Jan-Dec;27(1):1073274820960467. (PMID: 32938231) Transfusion. 2020 Oct;60(10):2210-2216. (PMID: 32770691) Front Immunol. 2021 Apr 27;12:618332. (PMID: 33986741) J Med Virol. 2022 Oct;94(10):4727-4734. (PMID: 35656698) Sci Immunol. 2019 Jun 28;4(36):. (PMID: 31253642) Swiss Med Wkly. 2022 Jan 06;152:w30133. (PMID: 35019196) Bioinformatics. 2019 Apr 15;35(8):1427-1429. (PMID: 30203022) Nat Med. 2020 Jul;26(7):1070-1076. (PMID: 32514174) Tohoku J Exp Med. 2020;250(4):271-278. (PMID: 32321874) Emerg Microbes Infect. 2020 Dec;9(1):680-686. (PMID: 32207377) Nat Biotechnol. 2020 Aug;38(8):970-979. (PMID: 32591762) Circ Res. 2020 Jun 5;126(12):1671-1681. (PMID: 32302265) Clin Pharmacol Ther. 2021 Sep;110(3):563-572. (PMID: 34216021) Biochem Pharmacol. 1988 Oct 1;37(19):3723-8. (PMID: 3178884) J Med Virol. 2021 Jul;93(7):4060-4062. (PMID: 33026669) Nat Med. 2020 Jun;26(6):842-844. (PMID: 32398875) Br J Pharmacol. 2004 Jul;142(6):933-42. (PMID: 15210574) BMJ Glob Health. 2021 Aug;6(8):. (PMID: 34373261) |
فهرسة مساهمة: | Keywords: Biostatistics & Bioinformatics; Infectious bronchitis virus; SARS coronavirus; Virus classification |
المشرفين على المادة: | 0 (Angiotensin Receptor Antagonists) 0 (Angiotensin-Converting Enzyme Inhibitors) 0 (Antihypertensive Agents) 0 (Calcium Channel Blockers) |
تواريخ الأحداث: | Date Created: 20220603 Date Completed: 20220818 Latest Revision: 20230209 |
رمز التحديث: | 20230209 |
مُعرف محوري في PubMed: | PMC9347732 |
DOI: | 10.1002/jmv.27914 |
PMID: | 35656698 |
قاعدة البيانات: | MEDLINE |
كن أول من يترك تعليقا!